$0.66
+0.02 (+2.40%)
Open$0.65
Previous Close$0.65
Day High$0.70
Day Low$0.63
52W High$4.62
52W Low$2.54
Volume—
Avg Volume724.4K
Market Cap15.52M
P/E Ratio44.91
EPS$0.08
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.85M | 7.13M | 6.14M |
| Net Income | -1,263,411 | -1,351,255 | -906,681 |
| Profit Margin | -18.4% | -19.0% | -14.8% |
| EBITDA | -2,085,898 | -2,131,542 | -1,625,986 |
| Free Cash Flow | -871,023 | -1,277,993 | -924,733 |
| Rev Growth | +20.2% | +21.4% | +12.5% |
| Debt/Equity | 0.33 | 0.37 | 0.29 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |